Simon Borghs

839 total citations
39 papers, 660 citations indexed

About

Simon Borghs is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Simon Borghs has authored 39 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 33 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Simon Borghs's work include Epilepsy research and treatment (39 papers), Pharmacological Effects and Toxicity Studies (33 papers) and Neuroscience and Neuropharmacology Research (11 papers). Simon Borghs is often cited by papers focused on Epilepsy research and treatment (39 papers), Pharmacological Effects and Toxicity Studies (33 papers) and Neuroscience and Neuropharmacology Research (11 papers). Simon Borghs collaborates with scholars based in United Kingdom, United States and Belgium. Simon Borghs's co-authors include Christine de la Loge, Joyce A. Cramer, Klaus Eckhardt, Stephen L. Yates, Wei Liang, Toufic Fakhoury, Joseph D’Souza, Peter Dedeken, Manuel Toledo and John Whitesides and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Epilepsia.

In The Last Decade

Simon Borghs

37 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Borghs United Kingdom 14 592 529 270 56 39 39 660
J. Eric Piña-Garza United States 16 722 1.2× 597 1.1× 203 0.8× 41 0.7× 40 1.0× 36 899
Ricardo Ayala United States 6 438 0.7× 410 0.8× 163 0.6× 61 1.1× 27 0.7× 20 549
Pascal Edrich United States 9 377 0.6× 343 0.6× 160 0.6× 65 1.2× 38 1.0× 13 449
J L Herranz Spain 14 542 0.9× 514 1.0× 112 0.4× 129 2.3× 33 0.8× 64 708
Alain Vuong United States 17 564 1.0× 522 1.0× 101 0.4× 49 0.9× 23 0.6× 25 710
Y. Sturm Switzerland 9 422 0.7× 418 0.8× 114 0.4× 66 1.2× 26 0.7× 11 513
Erik Sætre Norway 12 447 0.8× 424 0.8× 102 0.4× 38 0.7× 22 0.6× 18 547
Peter Dedeken Belgium 12 309 0.5× 272 0.5× 95 0.4× 53 0.9× 21 0.5× 35 413
R E Appleton United Kingdom 10 322 0.5× 290 0.5× 82 0.3× 21 0.4× 23 0.6× 13 405
Gregory S. Carter United States 5 337 0.6× 308 0.6× 109 0.4× 36 0.6× 28 0.7× 9 405

Countries citing papers authored by Simon Borghs

Since Specialization
Citations

This map shows the geographic impact of Simon Borghs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Borghs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Borghs more than expected).

Fields of papers citing papers by Simon Borghs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Borghs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Borghs. The network helps show where Simon Borghs may publish in the future.

Co-authorship network of co-authors of Simon Borghs

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Borghs. A scholar is included among the top collaborators of Simon Borghs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Borghs. Simon Borghs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mula, Marco, Simon Borghs, Gaetano Zaccara, et al.. (2023). Effect of drug treatment changes and seizure outcomes on depression and suicidality in adults with drug‐resistant focal epilepsy. Epilepsia. 65(2). 473–482. 2 indexed citations
3.
4.
Powell, Graham, J. Wells Logan, Victor A. Kiri, & Simon Borghs. (2019). Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records. BMJ Open. 9(12). e032551–e032551. 27 indexed citations
5.
6.
Toledo, Manuel, et al.. (2017). Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam. Epilepsy Research. 138. 53–61. 28 indexed citations
7.
8.
9.
10.
11.
Borghs, Simon, et al.. (2016). Understanding the Patient Perspective of Seizure Severity in Epilepsy: Development of a Conceptual Model. Patient. 9(5). 419–431. 3 indexed citations
12.
13.
Loge, Christine de la, Svetlana Dimova, Knut Mueller, et al.. (2016). PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life. Epilepsy & Behavior. 63. 20–28. 30 indexed citations
14.
Mulhern, Brendan, Joshua Pink, Donna Rowen, et al.. (2016). Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. Value in Health. 20(4). 687–693. 25 indexed citations
15.
Borghs, Simon, et al.. (2015). Health-Related Quality of Life In Double-Blind Phase Iii Studies of Brivaracetam As Adjunctive Therapy of Partial-Onset Seizures. Value in Health. 18(7). A762–A763. 2 indexed citations
16.
Escartín, Antonio, Frank Tennigkeit, Peter Dedeken, et al.. (2015). Safety and Effectiveness of Lacosamide as a First Add-on (FAO) or Later Add-on (LAO) Treatment of Partial-onset Seizures (POS) in Adults: an Open-label Trial (P4.262). Neurology. 84(14_supplement). 1 indexed citations
17.
Borghs, Simon, et al.. (2014). Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy: Real-Life Practice Data Using CPRD. Value in Health. 17(7). A403–A404. 1 indexed citations
18.
Cramer, Joyce A., Christine de la Loge, Yves Brabant, & Simon Borghs. (2013). Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ). Epilepsy & Behavior. 31. 286–290. 12 indexed citations
19.
Borghs, Simon, Christine de la Loge, Yves Brabant, & Joyce A. Cramer. (2013). Sensitivity testing of the Seizure Severity Questionnaire (SSQ). Epilepsy & Behavior. 31. 281–285. 11 indexed citations
20.
Borghs, Simon, Christine de la Loge, & Joyce A. Cramer. (2012). Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures. Epilepsy & Behavior. 23(3). 230–234. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Eric Piña-Garza Breakdown of academic impact, for papers by Ricardo Ayala Breakdown of academic impact, for papers by Pascal Edrich Breakdown of academic impact, for papers by J L Herranz Breakdown of academic impact, for papers by Alain Vuong Breakdown of academic impact, for papers by Y. Sturm Breakdown of academic impact, for papers by Erik Sætre Breakdown of academic impact, for papers by Peter Dedeken Breakdown of academic impact, for papers by R E Appleton Breakdown of academic impact, for papers by Gregory S. Carter
Rankless by CCL
2026